News
Purpose To characterize the number and functional status of CD4+CD25+ regulatory T cells (Tregs) in patients with metastatic melanoma (MM) and renal cell carcinoma (RCC) treated with high-dose bolus ...
A new research paper was published in Volume 16 of Oncotarget on July 9, 2025, titled “A novel anti-human CD25 mAb with ...
10d
News-Medical.Net on MSNNew monoclonal antibody enhances immune response by selectively targeting TregsA new research paper was published in Volume 16 of Oncotarget on July 9, 2025, titled "A novel anti-human CD25 mAb with ...
Their PBMC (peripheral blood mono nuclear cell) were harvested and investigated their character by FACScan (fluorescence-activated cell sorter scan) with fluorescent labeled antibodies (CD3, CD8, CD4, ...
13d
Sportschosun on MSNDonguibogam Palmultang-based additive prescription proves its effectiveness in restoring immunityThe Spinal Joint Research Institute (Director Ha In-hyuk) of Jaseng Oriental Medicine Hospital announced on the 14th that it ...
"CD4+ T cells can exist in a naive or memory state, can exhibit polarization to a Th1, Th2, Th17, or Tfh phenotype, or can be regulatory T cells," says lead author of the study Yoshiaki Yasumizu.
Indolent CD4+ cytotoxic chimeric antigen receptor (CAR) T-cell lymphoma involving the small intestine was diagnosed in a patient who had previously received ciltacabtagene autoleucel (cilta-cel ...
CD4 T-Cell Monitoring in HIV Management. Key Themes: Immune Reconstitution: Average CD4 count increases of approximately 200 cells in the first year of effective therapy Laboratory Variability ...
Researchers at Winship Cancer Institute of Emory University have identified a novel type of immune cell, called the stem-like CD4 T cell, that plays a pivotal role in anti-tumor immunity.
Idiopathic CD4 lymphocytopenia (ICL) was initially described in 1992 after opportunistic infections that are known to be associated with human immmunodeficiency virus (HIV) infection were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results